Displaying 1 to 1 of 1 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
EpimAb Biotherapeutics Biopharmaceutical company focused on bispecific antibodies. |
25 Apr 2017 | Series A Round participant. Active |